Seleno-organic compounds as immunostimulants: an approach to the structure-activity relationship. 1996

A D Inglot, and J Młochowski, and J Zielińska-Jenczylik, and E Piasecki, and T K Ledwoń, and K Kloc
Laboratory of Virology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Czerska, Wrocław, Poland.

Our studies on the seleno-organic compounds were focused at their activities as the modest cytokine inducers in human peripheral blood leukocyte cultures. Our bioassays used in the screening methods were based on the quantitative determinations of mainly two types of cytokines: interferons (IFNs) and tumor necrosis factors (TNFs). More recently we have found that several of the compounds have direct immunotropic actions in vitro and in vivo, in mice and in chickens. The paper summarizes the data related to the cytokine-inducing activity of 65 seleno-organic compounds divided into 4 groups according to their chemical structures. The reference compound was ebselen, the well known experimental drug with various biological activities. Approximately 50% of the compounds were found to be active in our bioassays. The selected compounds induced also IL-6 and GM-CSF. Their activities were clearly correlated with defined chemical structures as well as with the presence of selenium. We suggest that some of the selected by us compounds, other than ebselen, are interesting as immunostimulants and potential antiviral agents and cytokine inducers active in humans.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001393 Azoles Five membered rings containing a NITROGEN atom. Azole
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D016566 Organoselenium Compounds Organic compounds which contain selenium as an integral part of the molecule. Compounds, Organoselenium
D054833 Isoindoles Benzopyrroles with the nitrogen at the number two carbon, in contrast to INDOLES which have the nitrogen adjacent to the six-membered ring. Isoindole

Related Publications

A D Inglot, and J Młochowski, and J Zielińska-Jenczylik, and E Piasecki, and T K Ledwoń, and K Kloc
January 1996, SAR and QSAR in environmental research,
A D Inglot, and J Młochowski, and J Zielińska-Jenczylik, and E Piasecki, and T K Ledwoń, and K Kloc
June 2016, SAR and QSAR in environmental research,
A D Inglot, and J Młochowski, and J Zielińska-Jenczylik, and E Piasecki, and T K Ledwoń, and K Kloc
January 1984, Mutation research,
A D Inglot, and J Młochowski, and J Zielińska-Jenczylik, and E Piasecki, and T K Ledwoń, and K Kloc
September 2006, Chemical research in toxicology,
A D Inglot, and J Młochowski, and J Zielińska-Jenczylik, and E Piasecki, and T K Ledwoń, and K Kloc
October 2013, The Science of the total environment,
A D Inglot, and J Młochowski, and J Zielińska-Jenczylik, and E Piasecki, and T K Ledwoń, and K Kloc
July 1990, Arzneimittel-Forschung,
A D Inglot, and J Młochowski, and J Zielińska-Jenczylik, and E Piasecki, and T K Ledwoń, and K Kloc
January 1993, Yao xue xue bao = Acta pharmaceutica Sinica,
A D Inglot, and J Młochowski, and J Zielińska-Jenczylik, and E Piasecki, and T K Ledwoń, and K Kloc
January 1995, Biological trace element research,
A D Inglot, and J Młochowski, and J Zielińska-Jenczylik, and E Piasecki, and T K Ledwoń, and K Kloc
October 1987, Biochemical pharmacology,
A D Inglot, and J Młochowski, and J Zielińska-Jenczylik, and E Piasecki, and T K Ledwoń, and K Kloc
January 1992, Archivum immunologiae et therapiae experimentalis,
Copied contents to your clipboard!